Forest Hill Capital LLC boosted its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 25.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 172,809 shares of the company's stock after purchasing an additional 35,500 shares during the quarter. ZimVie accounts for about 1.9% of Forest Hill Capital LLC's portfolio, making the stock its 18th largest holding. Forest Hill Capital LLC owned approximately 0.63% of ZimVie worth $2,411,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its position in shares of ZimVie by 9.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company's stock valued at $17,367,000 after buying an additional 107,461 shares in the last quarter. American Century Companies Inc. increased its stake in ZimVie by 23.9% during the 4th quarter. American Century Companies Inc. now owns 628,050 shares of the company's stock worth $8,761,000 after acquiring an additional 121,053 shares during the period. Gamco Investors INC. ET AL raised its holdings in ZimVie by 15.1% in the 4th quarter. Gamco Investors INC. ET AL now owns 519,112 shares of the company's stock valued at $7,242,000 after acquiring an additional 68,176 shares in the last quarter. Northern Trust Corp lifted its position in shares of ZimVie by 3.5% during the 4th quarter. Northern Trust Corp now owns 326,252 shares of the company's stock valued at $4,551,000 after acquiring an additional 10,988 shares during the period. Finally, D. E. Shaw & Co. Inc. grew its holdings in shares of ZimVie by 12.1% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 301,316 shares of the company's stock worth $4,203,000 after purchasing an additional 32,551 shares in the last quarter. Institutional investors own 95.63% of the company's stock.
ZimVie Trading Down 4.7 %
Shares of ZIMV opened at $8.76 on Friday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie Inc. has a 52-week low of $8.56 and a 52-week high of $22.40. The firm has a market cap of $243.94 million, a price-to-earnings ratio of -0.67 and a beta of 2.16. The business's fifty day moving average is $10.32 and its 200-day moving average is $12.65.
ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.27 EPS for the quarter. The firm had revenue of $112.00 million during the quarter, compared to the consensus estimate of $113.10 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Equities analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of research analysts recently commented on ZIMV shares. Needham & Company LLC reaffirmed a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. B. Riley began coverage on shares of ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 target price for the company.
Check Out Our Latest Research Report on ZIMV
ZimVie Profile
(
Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.